TECH013: Monthly Tech Round-up - Davos WEF, Claude Cowork, Macrohard, w/ Seb Bunney (Tech Podcast) - We Study Billionaires Recap

Podcast: We Study Billionaires

Published: 2026-01-28

Duration: 1 hr 8 min

Guests: Seb Bunney

Summary

Seb Bunney and Preston Pisch discuss the transformative impact of AI, blockchain, and longevity science on the future of work and society. They explore tools like Claude Co-Work, ethical implications of AI, and potential disruptions in various industries.

What Happened

Seb Bunney and Preston Pisch dive into the rapid advancements in AI, highlighting how tools like Claude Co-Work are revolutionizing coding and organizational tasks. Claude has surpassed ChatGPT in coding capabilities, allowing users to create functional apps swiftly through web browsers without traditional app store deployment.

The conversation extends to the ethical considerations of AI relationships, referencing Claude's Soul, a document outlining Claude's ethical framework, which includes constraints like avoiding bioweapons. They discuss the growing trend of people forming relationships with AI models and its implications for human interaction.

Bunney and Pisch examine the concept of computation as the new currency in an AI-driven economy, likening it to Bitcoin's limited supply. The idea of computation units being traded like currency reflects the increasing importance of computational power in wealth generation.

The episode explores energy-efficient communication protocols, such as Tesla's new transmission protocol, which could significantly reduce energy costs. This innovation could transform AI infrastructure by enhancing communication efficiency and reducing operational expenses.

Blockchain's role in the future of equities is discussed, emphasizing the need for legal recognition of blockchain-based equities. They highlight the New York Stock Exchange's tokenization platform but stress that true on-chain equities require state-level blockchain node operation.

The potential for stem cell therapies to shift medicine from disease management to curing is examined. They mention a case where stem cell therapy restored insulin production in a diabetic patient, illustrating the promising applications of this technology in extending human lifespans.

Lastly, the episode touches on the broader implications of longevity science, with Peter Diamantis predicting the possibility of doubling human lifespans within five years. This potential shift could challenge traditional healthcare models that profit from prolonged sickness.

Key Insights